Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
Stifel Healthcare Conferenceon Tuesday, November 15, 2022at 10:55 AM ETin New York, NY
Jefferies London Healthcare Conferenceon Thursday, November 17, 2022at 8:30 AM ET/ 1:30 PM GMTin London, United Kingdom
Piper Sandler 34th Annual Healthcare Conference on
Tuesday, November 29, 2022at 4:00 PM ETin New York, NY
Live webcasts will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. All webcast replays will be archived on the Company’s website for 90 days following the presentation.
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in